ReviewCancers2021
Targeting CD82/KAI1 for Precision Therapeutics in Surmounting Metastatic Potential in Breast Cancer.
Maximillian Viera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ReviewCancers2021
Maximillian Viera et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.